Terms: = Colorectal cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
32 results:
1. Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs.
Kuznetcova I; Ostojić M; Gligorijević N; Aranđelović S; Arion VB
Inorg Chem; 2022 Dec; 61(50):20445-20460. PubMed ID: 36473464
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of adoptively transferred allogeneic CIK cells on colorectal cancer: Augmentative antitumoral effects of GvHD.
Muhammadnejad S; Monzavi SM; Torabi-Rahvar M; Sotoudeh M; Muhammadnejad A; Tavakoli-Shiraji S; Ranjbar A; Aghayan SS; Khorsand AA; Moradzadeh K; Janzamin E; Ahmadbeigi N
Int Immunopharmacol; 2023 Jan; 114():109446. PubMed ID: 36463696
[TBL] [Abstract] [Full Text] [Related]
3. T-Cell-Specific CerS4 Depletion Prolonged Inflammation and Enhanced Tumor Burden in the AOM/DSS-Induced CAC Model.
El-Hindi K; Brachtendorf S; Hartel JC; Oertel S; Birod K; Merz N; Trautmann S; Thomas D; Weigert A; Schäufele TJ; Scholich K; Schiffmann S; Ulshöfer T; Utermöhlen O; Grösch S
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163788
[TBL] [Abstract] [Full Text] [Related]
4. Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.
Tanaka A; Nishikawa H; Noguchi S; Sugiyama D; Morikawa H; Takeuchi Y; Ha D; Shigeta N; Kitawaki T; Maeda Y; Saito T; Shinohara Y; Kameoka Y; Iwaisako K; Monma F; Ohishi K; Karbach J; Jäger E; Sawada K; Katayama N; Takahashi N; Sakaguchi S
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31704808
[TBL] [Abstract] [Full Text] [Related]
5. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.
Yokoyama Y; Lew ED; Seelige R; Tindall EA; Walsh C; Fagan PC; Lee JY; Nevarez R; Oh J; Tucker KD; Chen M; Diliberto A; Vaaler H; Smith KM; Albert A; Li G; Bui JD
Cancer Res; 2019 Apr; 79(8):1996-2008. PubMed ID: 30723115
[TBL] [Abstract] [Full Text] [Related]
6. Potential biomarkers for the early diagnosis of colorectal adenocarcinoma - transcriptomic analysis of four clinical stages.
Janikowska G; Janikowski T; Pyka-Pająk A; Mazurek U; Janikowski M; Gonciarz M; Lorenc Z
Cancer Biomark; 2018; 22(1):89-99. PubMed ID: 29562499
[TBL] [Abstract] [Full Text] [Related]
7. Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase.
Matsueda S; Itoh K; Shichijo S
Cancer Sci; 2018 Mar; 109(3):611-617. PubMed ID: 29388341
[TBL] [Abstract] [Full Text] [Related]
8. Proteomic Features of colorectal cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
Clarke CN; Lee MS; Wei W; Manyam G; Jiang ZQ; Lu Y; Morris J; Broom B; Menter D; Vilar-Sanchez E; Raghav K; Eng C; Chang GJ; Simon I; Bernards R; Overman M; Mills GB; Maru D; Kopetz S
Ann Surg Oncol; 2017 Dec; 24(13):4051-4058. PubMed ID: 28936799
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract] [Full Text] [Related]
10. Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes.
Watanabe T; Kobunai T; Yamamoto Y; Kanazawa T; Konishi T; Tanaka T; Matsuda K; Ishihara S; Nozawa K; Eshima K; Muto T; Nagawa H
Eur J Cancer; 2010 Jul; 46(11):2119-26. PubMed ID: 20570135
[TBL] [Abstract] [Full Text] [Related]
11. Tyrosine phosphorylation of netrin receptors in netrin-1 signaling.
Ren XR; Hong Y; Feng Z; Yang HM; Mei L; Xiong WC
Neurosignals; 2008; 16(2-3):235-45. PubMed ID: 18253061
[TBL] [Abstract] [Full Text] [Related]
12. Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells.
Hirsch CL; Smith-Windsor EL; Bonham K
Int J Cancer; 2006 Feb; 118(3):547-54. PubMed ID: 16094635
[TBL] [Abstract] [Full Text] [Related]
13. [Expression of the p56lck by colon tumors: a marker of their invasive capacity?].
Rouer E
Bull Cancer; 2004 Dec; 91(12):928-40. PubMed ID: 15634634
[TBL] [Abstract] [Full Text] [Related]
14. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis.
Gardini A; Ercolani G; Riccobon A; Ravaioli M; Ridolfi L; Flamini E; Ridolfi R; Grazi GL; Cavallari A; Amadori D
J Surg Oncol; 2004 Jul; 87(1):46-52. PubMed ID: 15221919
[TBL] [Abstract] [Full Text] [Related]
15. Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.
De Paola F; Ridolfi R; Riccobon A; Flamini E; Barzanti F; Granato AM; Mordenti GL; Medri L; Vitali P; Amadori D
Br J Cancer; 2003 Jan; 88(2):320-6. PubMed ID: 12610520
[TBL] [Abstract] [Full Text] [Related]
16. Synthesis of antitumor dendritic imides.
Braña MF; Domínguez G; Sáez B; Romerdahl C; Robinson S; Barlozzari T
Bioorg Med Chem Lett; 2001 Dec; 11(23):3027-9. PubMed ID: 11714603
[TBL] [Abstract] [Full Text] [Related]
17. Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative.
Rose WC; Lee FY; Golik J; Kadow J
Cancer Chemother Pharmacol; 2000; 46(3):246-50. PubMed ID: 11021743
[TBL] [Abstract] [Full Text] [Related]
18. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.
Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D
Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141
[TBL] [Abstract] [Full Text] [Related]
20. Alteration of signal-transducing molecules in tumor-infiltrating lymphocytes and peripheral blood T lymphocytes from human colorectal carcinoma patients.
Choi SH; Chung EJ; Whang DY; Lee SS; Jang YS; Kim CW
Cancer Immunol Immunother; 1998 Feb; 45(6):299-305. PubMed ID: 9490199
[TBL] [Abstract] [Full Text] [Related]
[Next]
